Clonal diversity and biofilm-forming ability of methicillin-resistant Staphylococcus pseudintermedius

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 4, 2012, Pages 841-848

  Osland, Ane Mohr ^a   Vestby, Lene K ^a   Fanuelsen, Hanne ^a   Slettemeås, Jannice Schau ^a   Sunde, Marianne ^a  

^a NORWEGIAN VETERINARY INSTITUTE   (Norway)

Author keywords

Antimicrobial resistance; Dogs; Norway; Persistence; Sequence type

Indexed keywords

CEFALOTIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; KANAMYCIN; OXACILLIN; PENICILLIN G; POLYSTYRENE; TETRACYCLINE; TRIMETHOPRIM;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOFILM; BROTH DILUTION; CONTROLLED STUDY; EXPERIMENTAL DOG; GENETIC VARIABILITY; METHICILLIN RESISTANT STAPHYLOCOCCUS PSEUDINTERMEDIUS; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NORWAY; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CLUSTER ANALYSIS; DOG DISEASES; DOGS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENETIC VARIATION; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NORWAY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 84858640824     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr576     Document Type: Article

References (48)

1. Bannoehr J, Ben Zakour NL, Waller AS et al. Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains. J Bacteriol 2007; 189: 8685-92.
2. Devriese LA, Hermans K, Baele M et al. Staphylococcus pseudintermedius versus Staphylococcus intermedius. Vet Microbiol 2009; 133: 206-7.
3. Durdik P, Fedor M, Jesenak M et al. Staphylococcus intermedius-rare pathogen of acute meningitis. Int J Infect Dis 2010; 14 Suppl 3: e236-8.
4. Guardabassi L, Loeber ME, Jacobson A. Transmission of multiple antimicrobial-resistant Staphylococcus intermedius between dogs affected by deep pyoderma and their owners. Vet Microbiol 2004; 98: 23-7.
5. van Duijkeren E, Houwers DJ, Schoormans A et al. Transmission of methicillin-resistant Staphylococcus intermedius between humans and animals. Vet Microbiol 2008; 128: 213-5.
6. Riegel P, Jesel-Morel L, Laventie B et al. Coagulase positive Staphylococcus pseudintermedius from animals causing human endocarditis. Int J Med Microbiol 2010; 301: 237-9.
7. NORM/NORM-VET 2002. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø/Oslo, 2003. ISSN: 1502-2307.
8. NORM/NORM-VET 2004. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø/Oslo, 2005. ISSN: 1502-2307.
9. NORM/NORM-VET 2008. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø/Oslo, 2009. ISSN:1502-2307 (print)/1890-9965 (electronic).
10. De Lucia M, Moodley A, Latronico F et al. Prevalence of canine methicillin resistant Staphylococcus pseudintermedius in a veterinary diagnostic laboratory in Italy. Res Vet Sci 2011; 91: 346-8.
11. Loeffler A, Linek M, Moodley A et al. First report of multiresistant, mecA-positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet Dermatol 2007; 18: 412-21.
12. Ruscher C, Lübke-Becker A, Semmler T et al. Widespread rapid emergence of a distinct methicillin- and multidrug-resistant Staphylococcus pseudintermedius (MRSP) genetic lineage in Europe. Vet Microbiol 2010; 144: 340-6.
13. Schwarz S, Kadlec K, Strommenger B. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius detected in the BfT-GermVet monitoring programme 2004-2006 in Germany. J Antimicrob Chemother 2008; 61: 282-5.
14. Fluit AC, Schmitz FJ. MRSA: Current Perspectives. Norfolk: Caister Academic Press, 2003.
15. Perreten V, Kadlec K, Schwarz S et al. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother 2010; 65: 1145-54.
16. Black CC, Solyman SM, Eberlein LC et al. Identification of a predominant multilocus sequence type, pulsed-field gel electrophoresis cluster, and novel staphylococcal chromosomal cassette in clinical isolates of mecA-containing, methicillin-resistant Staphylococcus pseudintermedius. Vet Microbiol 2009; 139: 333-8.
17. Norstöm M, Sunde M, Tharaldsen H et al. Antimicrobial resistance in Staphylococcus pseudintermedius in the Norwegian dog population. Vet Microbiol 2009; 15: 55-9.
18. Futagawa-Saito K, Ba-TheinW, Sakurai N et al. Prevalence of virulence factors in Staphylococcus intermedius isolates from dogs and pigeons. BMC Vet Res 2006; 2: 4.
19. Hoiby N, Bjarnsholt T, Givskov M et al. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010; 35: 322-32.
20. Lønn-Stensrud J, Landin MA, Benneche T et al. Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections? J Antimicrob Chemother 2009; 63: 309-16.
21. Lopez D, Vlamakis H, Kolter R. Biofilms. Cold Spring Harb Perspect Biol 2010; 2: a000398.
22. O'Gara JP, Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol 2001; 50: 582-7.
23. Rode TM, Langsrud S, Holck A et al. Different patterns of biofilm formation in Staphylococcus aureus under food-related stress conditions. Int J Food Microbiol 2007; 116: 372-83.
24. Souza RR, Coelho LR, Botelho AM et al. Biofilm formation and prevalence of lukF-pv, seb, sec and tst genes among hospital- and community-acquired isolates of some international methicillin-resistant Staphylococcus aureus lineages. Clin Microbiol Infect 2009; 15: 203-7.
25. Dongari-Bagtzoglou A. Pathogenesis of mucosal biofilm infections: challenges and progress. Expert Rev Anti Infect Ther 2008; 6: 201-8.
26. Vestby L, Moretro T, Langsrud S et al. Biofilm forming abilities of Salmonella are correlated with persistence in fish meal- and feed factories. BMC Vet Res 2009; 5: 20.
27. Ziebuhr W, Hennig S, Eckart M et al. Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen. Int J Antimicrob Agents 2006; 28: 14-20.
28. Muir P, Johnson KA. Interlocking intramedullary nail stabilization of a femoral fracture in a dog with osteomyelitis. J Am Vet Med Assoc 1996; 209: 1262-4.
29. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002; 2: 677-85.
30. Bergan T, Bruun JN, Digranes A et al. Susceptibility testing of bacteria and fungi. Report from the Norwegian Working Group on Antibiotics. Scand J Infect Dis Suppl 1997; 103: 1-36.
31. Predari SC, Ligozzi M, Fontana R. Genotypic identification of methicillin-resistant coagulase-negative staphylococci by polymerase chain reaction. Antimicrob Agents Chemother 1991; 35: 2568-73.
32. Bannoehr J, Franco A, Iurescia M et al. Molecular diagnostic identification of Staphylococcus pseudintermedius. J Clin Microbiol 2009; 47: 469-71.
33. Tamura K, Peterson D, Peterson N et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28: 2731-9.
34. Bannerman TL, Hancock GA, Tenover FC et al. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol 1995; 33: 551-5.
35. Stepanović S, Vuković D, Hola V et al. Quantification of biofilm in microtitre plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007; 115: 891-9.
36. Petrie A, Watson P. Hypothesis tests 1-the t-test: comparing one or two means. In: Statistics for Veterinary and Animal Science, 2nd edn. Oxford: Blackwell Publishing, 2006; 83-94.
37. Vestby LK, Lonn-Stensrud J, Moretro T et al. A synthetic furanone potentiates the effect of disinfectants on Salmonella in biofilm. J Appl Microbiol 2010; 108: 771-8.
38. Felten A, Grandry B, Lagrange PH et al. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disc diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol 2002; 40: 2766-71.
39. Weese JS, Faires M, Brisson BA et al. Infection with methicillin-resistant Staphylococcus pseudintermedius masquerading as cefoxitin susceptible in a dog. J Am Vet Med Assoc 2009; 235: 1064-6.
40. Hassan A, Usman J, Kaleen F et al. Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis 2011; 15: 305-11.
41. Møretrø T, Vestby LK, Nesse LL et al. Evaluation of efficiency of disinfectants against Salmonella from the feed industry. J Appl Microbiol 2009; 106: 1005-12.
42. Cha J-O, Park Y-K, Lee YS et al. In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea. Diagn Microbiol Infect Dis 2011; 70: 112-8.
43. Hentzer M, Wu H, Andersen JB et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 2003; 22: 3803-15.
44. Jagusztyn-Krynicka EK, Wyszynska A. The decline of antibiotic era- new approaches for antibacterial drug discovery. Pol J Microbiol 2008; 57: 91-8.
45. Rasmussen TB, Givskov M. Quorum sensing inhibitors: a bargain of effects. Microbiology 2006; 152: 895-904.
46. Steenackers HPL, Ermolat'ev DS, Savaliya B et al. Structure-activity relationship of 4(5)-aryl-2-amino-1H-imidazoles, N1-substituted 2-aminoimidazoles and imidazo[1,2-a]pyrimidinium salts as inhibitors of biofilm formation by Salmonella Typhimurium and Pseudomonas aeruginosa. J Med Chem 2011; 54: 472-84.
47. Lønn-Stensrud J, Petersen FC, Benneche T et al. Synthetic bromated furanone inhibits autoinducer-2-mediated communication and biofilm formation in oral streptococci. Oral Microbiol Immunol 2007; 22: 340-6.
48. Rice SA, McDougald D, Kumar N et al. The use of quorum-sensing blockers as therapeutic agents for the control of biofilm-associated infections. Curr Opin Investig Drugs 2005; 6: 178-84.